AtomVie, Global

AtomVie Global Radiopharma Supplies First Patient Dose in Radiopharm Theranostics' Phase 1/ 2a Clinical Study of 177Lu-BetaBart

Published on 03/20/2026 at 07:49 | prnewswire.co.uk

AtomVie Global Radiopharma Inc. Ontario New York

en | boerse | 68926257 |